Sousa Andréa Cristina, Jardim Thiago Veiga, Costa Thiago Olivera, Magalhães Fabrício Galdino, Montelo Marcos Paulo Marinho, Souza Weimar K Barroso, Jardim Paulo César Brandão Veiga, Sousa Ana Luiza Lima
Hypertension League, Federal University of Goiás (Universidade Federal de Goiás), 1ª Avenida, S/N-Setor Leste Universitário, Goiânia, GO 74605-020 Brazil.
Medical School, Federal University of Goiás (Universidade Federal de Goiás), Goiânia, Brazil.
Diabetol Metab Syndr. 2017 Dec 21;9:98. doi: 10.1186/s13098-017-0296-z. eCollection 2017.
Diabetics have increased risks for cardiovascular disease (CVD) and mortality, reducing their life expectancy by up to 15 years. Type 2 diabetes mellitus specifically increases the risk for cardiovascular mortality nearly fivefold. When hypertension is combined with diabetes, the risk of CVD is even greater.
Identify non-fatal cardiovascular outcomes and renal function impairment in a cohort of hypertensive patients in regular treatment in a reference treatment center, over 11 years of follow-up.
Historical cohort of hypertensive patients in regular treatment for at least 11 years in a specialized service for hypertension treatment. The exposed group was hypertensive diabetic patients at the beginning of the cohort, and the non-exposed group had hypertension without diabetes. The cohort began in 2004, with follow-ups in 2009 and 2015. Variables used: gender, race, age, physical activity, alcohol consumption, smoking, blood pressure, body mass index, glycated hemoglobin, diabetes and hypertension diagnosis times, treatment time in specialized service, non-fatal cardiovascular outcomes, and renal impairment assessed by creatinine clearance.
139 patients participated in the study (55 diabetic hypertensive; 84 non-diabetic hypertensive), with an initial (2004) mean hypertension treatment time of 5.8 years. Females were the majority (75.5%) in both groups. Groups were similar regarding socio-demographic variables, but the group of hypertensive diabetic patients had higher frequency of obesity and uncontrolled BP, which persisted in all follow-ups. In 11 years of follow-up (2004-2015), the diabetic group had more cardiovascular events, with increased risk of acute myocardial infarction (RR 95% CI 1.6 12.2-95.0), stroke (RR 95% CI 1.3-6.1 27.7) and complications requiring hospitalization (RR 95% CI 1.6 2.2-3.0). Worsened renal function occurred more often in the non-exposed group, but in the end, the proportion of renal function loss was similar between groups.
Exposure to type 2 diabetes increased the risk of new cardiovascular outcomes over 11 years of follow-up of hypertensive patients. Diabetes by itself increased the risk of cardiovascular outcomes, justifying more intensive actions in this population.
糖尿病患者患心血管疾病(CVD)及死亡的风险增加,其预期寿命缩短可达15年。2型糖尿病尤其使心血管疾病死亡风险增加近五倍。当高血压与糖尿病并存时,CVD风险更高。
在一家参考治疗中心,对一组接受常规治疗的高血压患者进行超过11年的随访,以确定非致命性心血管结局和肾功能损害情况。
对在一家高血压治疗专科服务机构接受至少11年常规治疗的高血压患者进行历史性队列研究。暴露组为队列开始时的高血压糖尿病患者,非暴露组为无糖尿病的高血压患者。队列始于2004年,分别在2009年和2015年进行随访。使用的变量包括:性别、种族、年龄、身体活动、饮酒、吸烟、血压、体重指数、糖化血红蛋白、糖尿病和高血压诊断时间、在专科服务机构的治疗时间、非致命性心血管结局以及通过肌酐清除率评估的肾功能损害情况。
139名患者参与了研究(55名糖尿病高血压患者;84名非糖尿病高血压患者),初始(2004年)高血压平均治疗时间为5.8年。两组中女性均占多数(75.5%)。两组在社会人口统计学变量方面相似,但糖尿病高血压患者组肥胖和血压控制不佳的频率更高,在所有随访中均持续存在。在11年的随访(2004 - 2015年)中,糖尿病组发生更多心血管事件,急性心肌梗死风险增加(风险比95%置信区间1.6 - 12.2至95.0)、中风(风险比95%置信区间1.3 - 6.1至27.7)以及需要住院治疗的并发症(风险比95%置信区间1.6 - 2.2至3.0)。肾功能恶化在非暴露组更常发生,但最终两组肾功能丧失的比例相似。
在对高血压患者进行11年的随访中,暴露于2型糖尿病会增加新的心血管结局风险。糖尿病本身就增加了心血管结局风险,这证明应对该人群采取更强化的措施。